Cytokinetics Inc (CYTK)
54.21
+0.43
(+0.80%)
USD |
NASDAQ |
Jun 28, 16:00
54.19
-0.02
(-0.04%)
After-Hours: 20:00
Cytokinetics SG&A Expense (TTM): 169.45M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 169.45M |
December 31, 2023 | 173.61M |
September 30, 2023 | 183.47M |
June 30, 2023 | 191.58M |
March 31, 2023 | 194.57M |
December 31, 2022 | 177.98M |
September 30, 2022 | 157.81M |
June 30, 2022 | 135.79M |
March 31, 2022 | 114.28M |
December 31, 2021 | 96.80M |
September 30, 2021 | 76.90M |
June 30, 2021 | 63.00M |
March 31, 2021 | 55.97M |
December 31, 2020 | 52.82M |
September 30, 2020 | 49.50M |
June 30, 2020 | 46.95M |
March 31, 2020 | 42.62M |
December 31, 2019 | 39.61M |
September 30, 2019 | 36.58M |
June 30, 2019 | 34.00M |
March 31, 2019 | 32.20M |
December 31, 2018 | 32.03M |
September 30, 2018 | 34.73M |
June 30, 2018 | 37.22M |
March 31, 2018 | 37.62M |
Date | Value |
---|---|
December 31, 2017 | 36.47M |
September 30, 2017 | 32.88M |
June 30, 2017 | 30.44M |
March 31, 2017 | 29.10M |
December 31, 2016 | 27.82M |
September 30, 2016 | 26.68M |
June 30, 2016 | 24.74M |
March 31, 2016 | 22.14M |
December 31, 2015 | 19.67M |
September 30, 2015 | 18.70M |
June 30, 2015 | 17.41M |
March 31, 2015 | 17.38M |
December 31, 2014 | 17.27M |
September 30, 2014 | 16.80M |
June 30, 2014 | 16.44M |
March 31, 2014 | 15.72M |
December 31, 2013 | 15.09M |
September 30, 2013 | 14.81M |
June 30, 2013 | 14.17M |
March 31, 2013 | 13.01M |
December 31, 2012 | 12.43M |
September 30, 2012 | 11.48M |
June 30, 2012 | 11.69M |
March 31, 2012 | 13.31M |
December 31, 2011 | 13.59M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
36.58M
Minimum
Sep 2019
194.57M
Maximum
Mar 2023
108.38M
Average
96.80M
Median
Dec 2021
SG&A Expense (TTM) Benchmarks
Amgen Inc | 6.729B |
Gilead Sciences Inc | 6.147B |
Insmed Inc | 357.69M |
Eli Lilly and Co | 6.912B |
Avinger Inc | 14.93M |